INOVIO PHARMACEUTICALS INC's ticker is INO and the CUSIP is 45773H201. A total of 220 filers reported holding INOVIO PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14 | -6.7% | 35,300 | +5.4% | 0.00% | -50.0% |
| Q2 2023 | $15 | -11.8% | 33,500 | +59.5% | 0.00% | 0.0% |
| Q1 2023 | $17 | -41.4% | 21,000 | +12.3% | 0.00% | -33.3% |
| Q4 2022 | $29 | -99.9% | 18,700 | -39.9% | 0.00% | -50.0% |
| Q3 2022 | $54,000 | +1.9% | 31,100 | +1.5% | 0.01% | -14.3% |
| Q2 2022 | $53,000 | -51.8% | 30,650 | 0.0% | 0.01% | -36.4% |
| Q1 2022 | $110,000 | -23.6% | 30,650 | +6.2% | 0.01% | -8.3% |
| Q4 2021 | $144,000 | -42.4% | 28,851 | -17.5% | 0.01% | -42.9% |
| Q3 2021 | $250,000 | +4.2% | 34,951 | +35.2% | 0.02% | +5.0% |
| Q2 2021 | $240,000 | +10.6% | 25,851 | +10.7% | 0.02% | +17.6% |
| Q1 2021 | $217,000 | +102.8% | 23,351 | +93.8% | 0.02% | +88.9% |
| Q4 2020 | $107,000 | +386.4% | 12,051 | +12.6% | 0.01% | +125.0% |
| Q3 2019 | $22,000 | – | 10,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 200,000 | $998,000 | 0.36% |
| Green Alpha Advisors, LLC | 72,647 | $363,000 | 0.24% |
| Skaana Management L.P. | 227,851 | $1,137,000 | 0.18% |
| SEVEN EIGHT CAPITAL, LP | 196,351 | $980,000 | 0.18% |
| Defender Capital, LLC. | 103,038 | $514,000 | 0.16% |
| Skaana Management L.P. | 206,300 | $1,029,000 | 0.16% |
| WASATCH ADVISORS LP | 4,926,125 | $24,581,000 | 0.10% |
| Parametrica Management Ltd | 16,183 | $81,000 | 0.08% |
| Cedar Brook Financial Partners, LLC | 54,500 | $272,000 | 0.07% |
| Hennion & Walsh Asset Management, Inc. | 274,703 | $1,371,000 | 0.07% |